摘要
红斑狼疮是一种病因未明的慢性自身免疫性炎症性疾病,目前缺乏有效的治疗手段。红斑狼疮患者和小鼠模型显示了多方面的免疫学异常,在此基础上研发了影响自身反应性B细胞活化的治疗性抗体,正在进行临床检测。另外。
Lupus erythematosus is a chronic autoimmune inflammatory disease with largely unknown etiopathogenesis and no effective therapy. Human patients and murine models of lupus erythematosus manifest a wide range of immunological abnormalities. Therapeutic antibodies which affect the activation of potentially autoreactive B ceils have been developed and are being tested in clinical trials. In addition, preelinical studies have provided proof for the feasibility and efficacy of gene therapy in human lupus erythematosus.
出处
《国际生物制品学杂志》
CAS
2009年第4期209-213,共5页
International Journal of Biologicals
关键词
红斑狼疮
系统性
抗体
单克隆
基因疗法
Lupus erythematosus, systemic
Antibodies, monoclonal
Gene therapy